MediWound (MDWD) Net Margin (2014 - 2025)

MediWound (MDWD) recorded quarterly Net Margin of 413.87% in Q4 2025, down 247.17% quarter-over-quarter from 119.21% in Q3 2025, and down 30971.0% on a YoY basis from N/an in Q4 2024.

MediWound (MDWD) Net Margin (2014 - 2025) Analysis & Trends

MediWound's Net Margin history runs 12 years deep, the most recent figure standing at 413.87% for Q4 2025.

  • In Q4 2025, Net Margin fell 30971.0% year-over-year to 413.87%; the TTM figure through Dec 2025 stood at 215.94% (down 10255.0% YoY), while the FY2025 annual figure was 138.81%, up 1005.0% from the prior year.
  • Net Margin was 413.87% for Q4 2025 at MediWound, down from 119.21% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 26.6% in Q2 2023 to a low of 413.87% in Q4 2025.
  • Historically, Net Margin has averaged 119.55% across 5 years, with a median of 96.97% in 2021.
  • The sharpest annual moves came in 2023 and 2025: Net Margin jumped 18310 bps in 2023, then tumbled 30971 bps in 2025.
  • A 5-year view of Net Margin shows it stood at 75.67% in 2021, then increased by 17 bps to 63.07% in 2022, then jumped by 55 bps to 28.16% in 2023, then tumbled by 270 bps to 104.16% in 2024, then plunged by 297 bps to 413.87% in 2025.
  • The last three Net Margin figures came in at 413.87% (Q4 2025), 119.21% (Q3 2025), and 341.82% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.82%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 34.53%
9 Abivax 94.37 Bn 94.37 Bn - -
10 MediWound 3.70 Mn 3.70 Mn 278,000.00 -413.87%

Historic Data

Download Data
DateValue
Dec 31, 2025 -413.87%
Sep 30, 2025 -119.21%
Jun 30, 2025 -341.82%
Mar 31, 2025 -131.98%
Dec 31, 2024 -104.16%
Sep 30, 2024 -116.19%
Jun 30, 2024 -180.05%
Mar 31, 2024 -74.74%
Dec 31, 2023 -28.16%
Sep 30, 2023 -43.97%
Jun 30, 2023 26.60%
Mar 31, 2023 -96.95%
Dec 31, 2022 -63.07%
Sep 30, 2022 -72.19%
Jun 30, 2022 -156.50%
Mar 31, 2022 -81.26%
Dec 31, 2021 -75.67%
Sep 30, 2021 -101.21%
Mar 31, 2021 -96.97%
Dec 31, 2020 -0.04%